|
Affiliation |
Faculty of Medicine College Hospital Intensive care part |
|
Title |
Associate Professor |
|
External Link |
|
|
Related SDGs |
|
TANIGUCHI Masahiko
|
|
|
Degree 【 display / non-display 】
-
Doctor (Medicine) ( 1996.3 Miyazaki Medical College )
-
医学（医学） ( 1990.3 宮崎医科大学 )
Papers 【 display / non-display 】
-
症例報告 自己免疫性肺胞タンパク症に対する全肺洗浄法においてスマートベスト®を使用した1症例 Reviewed
米良 舞, 永田 悠紀子, 矢野 武志, 石山 健次郎, 谷口 正彦, 恒吉 勇男
麻酔 74 ( 6 ) 393 - 396 2025.6
Publishing type：Research paper (scientific journal) Publisher：克誠堂出版
-
Removal characteristics of presepsin by operating conditions and hemofilter Reviewed
Yamasaki T., Miyamoto Y., Goto T., Oda Y., Yano T., Taniguchi M., Shirasaka T.
Journal of Artificial Organs 27 ( 3 ) 321 - 323 2024.9
Language：English Publishing type：Research paper (scientific journal) Publisher：Journal of Artificial Organs
Presepsin, which is used as a biomarker for sepsis, is thought to be removed by dialysis, but the actual removal properties of dialysis are unknown. We investigated the presepsin removal properties of continuous hemodiafiltration using the high concentration of presepsin from human plasma drained by plasma exchange. Each solution in plasma exchange was connected to a continuous hemodiafiltration blood circuit and circulated at 4 conditions. The results show that presepsin was confirmed to be removed more efficiently in hemofiltration than in hemodialysis. In addition, when using a polymethylmethacrylate hemofilter for continuous hemodiafiltration, the lowest presepsin concentration is on the filtrate side, suggesting that the main removal mechanism is adsorption. Since presepsin has a molecular weight of 13,000, its removal efficiency is high by hemofiltration as per principle. In addition, since the main adsorption principle of polymethylmethacrylate hemofilter is hydrophobic bond, presepsin is considered to be adsorbed. Since presepsin is metabolized in the kidney, it is elevated in renal failure. In this paper, we confirmed that presepsin is eliminated by continuous hemodiafiltration not only in the kidney. Depending on the timing of presepsin measurement, there is a risk of missing the diagnosis of sepsis. Kidney function and continuous hemodiafiltration should be checked when measuring presepsin.
-
症例報告 胸腺腫による心圧排所見を伴う発作性心房細動に対してランジオロールが奏効した1症例 Reviewed
興梠 聡志, 矢野 武志, 村社 瑞穂, 長嶺 佳弘, 古澤 高廣, 長濵 真澄, 與那覇 哲, 谷口 正彦, 恒吉 勇男
麻酔 72 ( 3 ) 285 - 290 2023.3
Publishing type：Research paper (scientific journal) Publisher：克誠堂出版
-
Furusawa Takahiro, Yano Takeshi, Kashino Rina, Yoshikai Mizuho, Koshida Tomohiro, Yonaha Tetsu, Taniguchi Masahiko, Tsuneyoshi Isao
Journal of the Japanese Society of Intensive Care Medicine 30 ( 1 ) 23 - 24 2023.1
Language：Japanese Publishing type：Research paper (scientific journal) Publisher：The Japanese Society of Intensive Care Medicine
DOI： 10.3918/jsicm.30_23
-
Comparison of permeability and antithrombotic properties of two Polysulfone (PS) membranes Reviewed
Yamasaki Tatsumi, Adachi Nene, Oda Yuuichi, Yano Takeshi, Taniguchi Masahiko, Shirasaka Tetsuro
Journal of Japan Society for Blood Purification in Critical Care 13 ( 1 ) 64 - 68 2022.6
Language：Japanese Publishing type：Research paper (scientific journal) Publisher：Japan Society for Blood Purification in Critical Care
In recent years, HEMOFEEL<sup>®</sup> SNV, in which an NV polymer is localized on the inner surface of the hollow fiber of a Polysulfone (PS) membrane hemofilter, has been sold. NV polymers are believed to have improved antithrombotic properties by suppressing protein adhesion (fouling). In order to investigate the permeability and antithrombotic properties of HEMOFEEL<sup>®</sup> SNV, we compared it with other companies’ PS membrane hemofilters. The subjects were 56 adult patients who underwent CHDF (continuous hemodiafiltration) using PS membrane hemofilters, and the number of membranes was 226. The patients were divided into the EXCELFLO<sup>®</sup> AEF-13 group and the HEMOFEEL<sup>®</sup> SNV-1.3 group, and the transmembrane pressure (TMP), ultrafiltration rate (UFR), and lifetime were compared. The results suggested that the HEMOFEEL<sup>®</sup> SNV-1.3 group had significantly lower TMP and significantly higher UFR, which was advantageous for high flow rate filtration settings.
Books 【 display / non-display 】
-
麻酔偶発症A to Z
谷口正彦（ Role： Contributor , 局所麻酔薬の心毒性．）
文光堂 2017.6
Responsible for pages：477-478 Language：Japanese Book type：Scholarly book
-
麻酔偶発症A to Z
谷口正彦（ Role： Contributor , メトヘモグロビン血症．）
文光堂 2017.6
Responsible for pages：474 Language：Japanese Book type：Scholarly book
-
麻酔科医のための周術期の薬物使用法-ミルリノン
谷口正彦, 恒吉勇男（ Role： Joint author , 全身管理薬ーミルリノン pp208-211）
中山書店 2015.4
Language：Japanese Book type：Scholarly book
-
麻酔科医のための周術期の薬物使用法-イソプレナリン
谷口正彦, 矢野武志, 恒吉勇男（ Role： Joint author , 全身管理薬ーイソプレナリン pp206-208）
中山書店 2015.4
Language：Japanese Book type：Scholarly book
-
集中治療医学講座13，気管切開―最新の手技と管理―
谷口正彦（ Role： Edit , 私のコツ：Blue-Rhino(COOK)）
医学図書出版株式会社 2011.6
Language：Japanese Book type：Scholarly book
MISC 【 display / non-display 】
-
局所麻酔薬とオピオイドの硬膜外投与
谷口 正彦,髙崎 真弓
ペインクリニック 26 S233 - S238 2005.3
Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (scientific journal) Publisher：真興交易
-
腕神経叢ブロックの成功率を上げる方法
谷口 正彦,河野 太郎,與那覇 哲,田村 隆二,丸田 豊明,矢野 武志,大久保 重明,柏田 政利,三浦 弘樹,岩崎 竜馬,松岡 博史,立山 真吾,吉村 安広,成尾 浩明,白阪 哲朗,田中 信彦,指宿 昌一郎,鈴木 宣彰,笠羽 敏治,髙崎 真弓
臨床麻酔 28 ( 6 ) 1081 - 1086 2004.6
Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (scientific journal) Publisher：真興交易
Presentations 【 display / non-display 】
-
選択的血漿交換療法が奏効した抗体陰性視神経脊髄炎の１症例．
越田智広，山下幸貴，與那覇 哲，内村修二，興梠聡志，米良 舞，谷口正彦，恒吉勇男
第52回日本集中治療医学会学術集会
Event date： 2025.3.14 - 2025.3.16
Language：Japanese Presentation type：Poster presentation
-
経皮的気管切開時に気管切開チューブが気管膜様部の瘻孔へ迷入し換気困難となった 1 症例．
深尾 麻由，矢野 武志，與那覇 哲，谷口 正彦，恒吉 勇男
第52回日本集中治療医学会学術集会 2025.3.15
Event date： 2025.3.14 - 2025.3.16
Language：Japanese Presentation type：Poster presentation
-
高度肥満が原因で緊急開腹術後に呼吸管理に難渋した１例．
丸田豊明、興梠聡志、米良舞、内村修二、越田智広、與那覇哲、山下幸貴、谷口正彦、恒吉勇男
第39回日本救命医療学会総会・学術集会 2024.9.21
Event date： 2024.9.21
Language：Japanese Presentation type：Oral presentation (general)
-
V-V ECMO管理中に胸腔ドレナージを契機とした大量血胸を発症しIVRで止血し得た１例．
山下幸貴，古澤高廣，永田悠紀子，興梠聡志，内村修二,谷口正彦，恒吉勇男
日本集中治療医学会第８回九州支部学術集会 2024.7.27
Event date： 2024.7.27
Language：Japanese Presentation type：Oral presentation (general)
-
意識障害が遷延し診断に難渋した持続性副腎不全のⅠ症例．
興梠聡志，與那覇 哲，永田悠紀子，内村修二，古澤高廣，山下幸貴，谷口正彦，恒吉勇男
日本集中治療医学会第８回九州支部学術集会 2024.7.27
Event date： 2024.7.27
Language：Japanese Presentation type：Oral presentation (general)
Grant-in-Aid for Scientific Research 【 display / non-display 】
-
局所麻酔薬の神経毒性とフリーラジカル
Grant number：15790823 2004.04 - 2005.03
科学研究費補助金 若手研究(B)